History of the design of captopril and related inhibitors of angiotensin converting enzyme.
- 1 April 1991
- journal article
- review article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 17 (4), 589-592
- https://doi.org/10.1161/01.hyp.17.4.589
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Reminiscences in Pharmacology: Auld Acquaintance Ne'er ForgotAnnual Review of Pharmacology and Toxicology, 1985
- Captopril (SQ 14,225) (d-3-mercapto-2-methylpropanoyl-l-proline): A novel orally active inhibitor of angiotensin-converting enzyme and antihypertensive agentProgress in Cardiovascular Diseases, 1978
- An Angiotensin Converting-Enzyme Inhibitor to Identify and Treat Vasoconstrictor and Volume Factors in Hypertensive PatientsNew England Journal of Medicine, 1974
- Inhibition of angiotensin-converting enzyme by analogs of peptides fromBothrops jararaca venomCellular and Molecular Life Sciences, 1973
- Binding of the by-product analog benzylsuccinic acid by carboxypeptidase ABiochemistry, 1973
- Inhibition of homogeneous angiotensin-converting enzyme of rabbit lung by synthetic venom peptides of Bothrops jararacaBiochimica et Biophysica Acta (BBA) - Enzymology, 1973
- Angiotensin-converting enzyme inhibitors from the venom of Bothrops jararaca. Isolation, elucidation of structure, and synthesisBiochemistry, 1971
- Isolation of bradykinin-potentiating peptides from Bothrops jararaca venomBiochemistry, 1970
- Conversion of Angiotensin I to Angiotensin II by Cell-free Extracts of Dog LungNature, 1968
- A BRADYKININ‐POTENTIATING FACTOR (BPF) PRESENT IN THE VENOM OF BOTHROPS JARARACABritish Journal of Pharmacology and Chemotherapy, 1965